Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tofacitinib in Ocular Inflammation: Experience from a Tertiary Eye Centre in South India.

Ocular immunology and inflammation·2025

Same author

Efficacy of Tofacitinib in Takayasu Arteritis Refractory to Biologic DMARDs-A Multicentre Study in Indian Patients.

International journal of rheumatic diseases·2025

Same author

Infection associated Vasculitides.

Best practice & research. Clinical rheumatology·2025

Same author

Rituximab Related Reactivation of SARS-CoV-2 and Prolonged COVID-19 in a Person with Multiple Sclerosis.

Neurology India·2024

Same author

Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis.

Autoimmunity reviews·2024

Same author

Biologics in ocular inflammatory diseases - Experience from a tertiary referral eye care center in South India.

Indian journal of ophthalmology·2024

Search research articles

Related Experiment Video

Updated: Sep 15, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Primary Central Nervous System Vasculitis - Long Term Clinical Course and Treatment Response.

Seetharam Raghavendra¹, Jaychandran Ramachandran¹, Javeria Nooraine¹

¹Department of Neurology, Manipal Hospital (Formerly Vikram Hospital), Millers Road, Bangalore, Karnataka, India.

Neurology India

|July 13, 2025

Summary

Primary CNS Vasculitis (PCNSV) requires aggressive immunosuppression for disease control, despite risks. Long-term follow-up is crucial for managing this challenging condition.

Keywords:

Primary central nervous system vasculitis diagnosis outcome treatment

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

Related Experiment Videos

Last Updated: Sep 15, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

Area of Science:

Neurology
Immunology
Vascular Medicine

Background:

Primary CNS Vasculitis (PCNSV) is a rare inflammatory condition affecting central nervous system blood vessels.
Diagnosis and long-term outcomes of PCNSV remain challenging.

Purpose of the Study:

To investigate the clinical progression and long-term outcomes of patients diagnosed with biopsy-proven PCNSV.

Main Methods:

Retrospective review of clinical data from eight patients with biopsy-confirmed PCNSV.
Patients underwent thorough evaluation to exclude secondary causes of vasculitis.

Main Results:

Presenting symptoms included focal neurological deficits, seizures, headache, and cognitive decline.
MRI revealed multifocal signal changes, microhemorrhages, and contrast enhancement.
Immunosuppressive therapy, including methylprednisolone and cyclophosphamide, led to disease control, but relapses occurred, necessitating treatment escalation. Rituximab showed benefit in select cases.

Conclusions:

PCNSV presents variably and poses diagnostic challenges.
Effective immunosuppressive therapy is vital but carries risks.
Histopathological confirmation, early aggressive treatment, and close clinico-radiological monitoring are key for successful long-term management and remission.